| 1. |
Wypych TP, Wickramasinghe LC, Marsland BJ. The influence of the microbiome on respiratory health. Nat Immunol, 2019, 20(10): 1279-1290.
|
| 2. |
于翠香, 王西艳. 中国成人医院获得性肺炎与呼吸机相关性肺炎诊断和治疗指南(2018年版)解读. 中国医刊, 2021, 56(9): 951-953.
|
| 3. |
Zhang J, Wu Y, Liu J, et al. Differential oral microbial input determines two microbiota pneumo-types associated with health status. Adv Sci, 2022, 9(32): e2203115.
|
| 4. |
Pinheiro CLS, Lima FP, Machado FC, et al. Oral and tracheal microbiota of pediatric and adolescent patients in an intensive care unit. Spec Care Dentist, 2021, 41(5): 599-606.
|
| 5. |
Su L, Qiao Y, Luo J, et al. Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices. J Transl Med, 2022, 20(1): 76.
|
| 6. |
邓石坤, 植丽佳, 高培阳. 经气管插管机械通气对呼吸道菌群影响的研究进展. 中国呼吸与危重监护杂志, 2022, 21(3): 221-224.
|
| 7. |
Hong L, Chen Y, Ye L. Characteristics of the lung microbiota in lower respiratory tract infections with and without history of pneumonia. Bioengineered, 2021, 12(2): 10480-10490.
|
| 8. |
Zhan D, Li D, Yuan K, et al. Characteristics of the pulmonary microbiota in patients with mild and severe pulmonary infection. Front Cell Infect Microbiol, 2023, 13: 1227581.
|
| 9. |
Woo S, Park SY, Kim Y, et al. The dynamics of respiratory microbiota during mechanical ventilation in patients with pneumonia. J Clin Med, 2020, 9(3): 638.
|
| 10. |
Yang D, Xing Y, Song X, et al. The impact of lung microbiota dysbiosis on inflammation. Immunology, 2020, 159(2): 156-166.
|
| 11. |
Dickson RP, Erb-Downward JR, Freeman CM, et al. Spatial variation in the healthy human lung microbiome and the adapted island model of lung biogeography. Ann Am Thorac Soc, 2015, 12(6): 821-830.
|
| 12. |
Gaeckle NT, Pragman AA, Pendleton KM, et al. The oral-lung axis: the impact of oral health on lung health. Respir Care, 2020, 65(8): 1211-1220.
|
| 13. |
Li Z, Li Y, Sun Q, et al. Targeting the pulmonary microbiota to fight against respiratory diseases. Cells, 2022, 11(5): 916.
|
| 14. |
Li R, Li J, Zhou X. Lung microbiome: new insights into the pathogenesis of respiratory diseases. Signal Transduct Target Ther, 2024, 9(1): 19.
|
| 15. |
Fahy JV, Dickey BF. Airway mucus function and dysfunction. N Engl J Med, 2010, 363(23): 2233-2247.
|
| 16. |
Invernizzi R, Lloyd CM, Molyneaux PL. Respiratory microbiome and epithelial interactions shape immunity in the lungs. Immunology, 2020, 160(2): 171-182.
|
| 17. |
Ganjian H, Rajput C, Elzoheiry M, et al. Rhinovirus and innate immune function of airway epithelium. Front Cell Infect Microbiol, 2020, 10: 277.
|
| 18. |
Sommariva M, Le Noci V, Bianchi F, et al. The lung microbiota: role in maintaining pulmonary immune homeostasis and its implications in cancer development and therapy. Cell Mol Life Sci, 2020, 77(14): 2739-2749.
|
| 19. |
Wu BG, Segal LN. Lung microbiota and its impact on the mucosal immune phenotype. Microbiol Spectr, 2017, 5(3): ebad-0005-2016.
|
| 20. |
Cheng M, Hu S. Lung-resident γδ T cells and their roles in lung diseases. Immunology, 2017, 151(4): 375-384.
|
| 21. |
Jatzlauk G, Bartel S, Heine H, et al. Influences of environmental bacteria and their metabolites on allergies, asthma, and host microbiota. Allergy, 2017, 72(12): 1859-1867.
|
| 22. |
Gao L, Xu T, Huang G, et al. Oral microbiomes: more and more importance in oral cavity and whole body. Protein Cell, 2018, 9(5): 488-500.
|
| 23. |
Verma D, Garg PK, Dubey AK. Insights into the human oral microbiome. Arch Microbiol, 2018, 200(4): 525-540.
|
| 24. |
Thibeault C, Suttorp N, Opitz B. The microbiota in pneumonia: from protection to predisposition. Sci Transl Med, 2021, 13(576): eaba0501.
|
| 25. |
Wu BG, Sulaiman I, Tsay JJ, et al. Episodic aspiration with oral commensals induces a MyD88-dependent, pulmonary T-helper cell type 17 response that mitigates susceptibility to Streptococcus pneumoniae. Am J Respir Crit Care Med, 2021, 203(9): 1099-1111.
|
| 26. |
Bao L, Zhang C, Dong J, et al. Oral microbiome and SARS-CoV-2: beware of lung co-infection. Front Microbiol, 2020, 11: 1840.
|
| 27. |
Hernández-Cabanyero C, Vonaesch P. Ectopic colonization by oral bacteria as an emerging theme in health and disease. FEMS Microbiol Rev, 2024, 48(2): fuae012.
|
| 28. |
杨海珍, 胡克. 牙周疾病对慢性阻塞性肺疾病预后的影响. 中国呼吸与危重监护杂志, 2023, 22(8): 605-608.
|
| 29. |
蒋素妹, 马元, 王正霞, 等. 慢性阻塞性肺疾病稳定期口咽部炎性标志物变化的临床意义. 中国呼吸与危重监护杂志, 2022, 21(7): 459-464.
|
| 30. |
Tonetti FR, Islam MA, Vizoso-Pinto MG, et al. Nasal priming with immunobiotic lactobacilli improves the adaptive immune response against influenza virus. Int Immunopharmacol, 2020, 78: 106115.
|
| 31. |
Wang Q, Lin X, Xiang X, et al. Oropharyngeal probiotic ENT-K12 prevents respiratory tract infections among frontline medical staff fighting against COVID-19: a pilot study. Front Bioeng Biotechnol, 2021, 9: 646184.
|
| 32. |
Fu J, Liu X, Cui Z, et al. Probiotic-based nanoparticles for targeted microbiota modulation and immune restoration in bacterial pneumonia. Natl Sci Rev, 2022, 10(2): nwac221.
|
| 33. |
Shukla SD, Budden KF, Neal R, et al. Microbiome effects on immunity, health and disease in the lung. Clin Transl Immunology, 2017, 6(3): e133.
|
| 34. |
Li KL, Wang BZ, Li ZP, et al. Alterations of intestinal flora and the effects of probiotics in children with recurrent respiratory tract infection. World J Pediatr, 2019, 15(3): 255-261.
|
| 35. |
Feng Q, Chen WD, Wang YD. Gut microbiota: an integral moderator in health and disease. Front Microbiol, 2018, 9: 151.
|
| 36. |
Dang AT, Marsland BJ. Microbes, metabolites, and the gut-lung axis. Mucosal Immunol, 2019, 12(4): 843-850.
|
| 37. |
Rastogi S, Mohanty S, Sharma S, et al. Possible role of gut microbes and host's immune response in gut-lung homeostasis. Front Immunol, 2022, 13: 954339.
|
| 38. |
Verma A, Bhagchandani T, Rai A, et al. Short-chain fatty acid (SCFA) as a connecting link between microbiota and gut-lung axis-a potential therapeutic intervention to improve lung health. ACS omega, 2024, 9(13): 14648-14671.
|
| 39. |
莫春燕, 娄熙冉, 陈国兵. 肠道菌群代谢产物在脓毒症中的研究进展. 中国急救医学, 2023, 43(3): 239-242.
|
| 40. |
邵瑞飞, 杨艳, 郑志榕, 等. 肠道菌群和“肠-肺”轴在脓毒症中的作用. 基础医学与临床, 2020, 40(8): 1109-1112.
|
| 41. |
Jin C, Chen J, Gu J, et al. Gut-lymph-lung pathway mediates sepsis-induced acute lung injury. Chin Med J (Engl), 2020, 133(18): 2212-2218.
|
| 42. |
Wheatley RM, Caballero JD, van der Schalk TE, et al. Gut to lung translocation and antibiotic mediated selection shape the dynamics of Pseudomonas aeruginosa in an ICU patient. Nat Commun, 2022, 13(1): 6523.
|
| 43. |
Wang L, Cai Y, Garssen J, et al. The bidirectional gut-lung axis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2023, 207(9): 1145-1160.
|
| 44. |
Yadav MK, Kumari I, Singh B, et al. Probiotics, prebiotics and synbiotics: safe options for next-generation therapeutics. Appl Microbiol Biotechnol, 2022, 106(2): 505-521.
|
| 45. |
Oksi J, Anttila VJ, Mattila E. Treatment of Clostridioides (Clostridium) difficile infection. Ann Med, 2020, 52(1-2): 12-20.
|
| 46. |
Tang Y, Chen L, Yang J, et al. Gut microbes improve prognosis of Klebsiella pneumoniae pulmonary infection through the lung-gut axis. Front Cell Infect Microbiol, 2024, 14: 1392376.
|
1/5
WeChat